Differential Reactivity of Germ Line Allelic Variants of a Broadly Neutralizing HIV-1 Antibody to a gp41 Fusion Intermediate Conformation

被引:48
|
作者
Alam, S. Munir [1 ]
Liao, Hua-Xin [1 ]
Dennison, S. Moses [1 ]
Jaeger, Frederick [1 ]
Parks, Robert [1 ]
Anasti, Kara [1 ]
Foulger, Andrew [1 ]
Donathan, Michele [1 ]
Lucas, Judith [1 ]
Verkoczy, Laurent [1 ]
Nicely, Nathan [1 ]
Tomaras, Georgia D. [1 ]
Kelsoe, Garnett [1 ,2 ,3 ,4 ]
Chen, Bing [5 ]
Kepler, Thomas B. [1 ,6 ]
Haynes, Barton F. [1 ,2 ,3 ,4 ]
机构
[1] Duke Univ, Duke Human Vaccine Inst, Durham, NC 27710 USA
[2] Duke Univ, Dept Med, Durham, NC 27710 USA
[3] Duke Univ, Dept Surg, Durham, NC 27710 USA
[4] Duke Univ, Dept Immunol, Durham, NC 27710 USA
[5] Harvard Univ, Sch Med, Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA
[6] Duke Univ, Ctr Computat Immunol, Durham, NC 27710 USA
基金
比尔及梅琳达.盖茨基金会;
关键词
CHAIN VARIABLE-REGION; PROXIMAL EXTERNAL REGION; MONOCLONAL-ANTIBODY; MEMBRANE; 2F5; GENE; 4E10; RESPONSES; AFFINITY; BINDING;
D O I
10.1128/JVI.05680-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Genetic factors, as well as antigenic stimuli, can influence antibody repertoire formation. Moreover, the affinity of antigen for unmutated naive B cell receptors determines the threshold for activation of germinal center antibody responses. The gp41 2F5 broadly neutralizing antibody (bNAb) uses the V(H)2-5 gene, which has 10 distinct alleles that use either a heavy-chain complementarity-determining region 2 (HCDR2) aspartic acid (D-H54) or an HCDR2 asparagine (N-H54) residue. The 2F5 HCDR2 D-H54 residue has been shown to form a salt bridge with gp41 K-665; the V(H)2-5 germ line allele variant containing N-H54 cannot do so and thus should bind less avidly to gp41. Thus, the induction of 2F5 bNAb is dependent on both genetic and structural factors that could affect antigen affinity of unmutated naive B cell receptors. Here, we studied allelic variants of the V(H)2-5 inferred germ line forms of the HIV-1 gp41 bNAb 2F5 for their antigen binding affinities to gp41 linear peptide and conformational protein antigens. Both V(H)2-5 2F5 inferred germ line variants bound to gp41 peptides and protein, including the fusion intermediate protein mimic, although more weakly than the mature 2F5 antibody. As predicted, the affinity of the N-H54 variant for fusion-intermediate conformation was an order of magnitude lower than that of the D-H54 V(H)2-5 germ line antibody, demonstrating that allelic variants of 2F5 germ line antibodies differentially bind to gp41. Thus, these data demonstrate a genetically determined trait that may affect host responses to HIV-1 envelope epitopes recognized by broadly neutralizing antibodies and has implications for unmutated ancestor-based immunogen design.
引用
收藏
页码:11725 / 11731
页数:7
相关论文
共 50 条
  • [1] A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies
    Frey, Gary
    Peng, Hanqin
    Rits-Volloch, Sophia
    Morelli, Marco
    Cheng, Yifan
    Chen, Bing
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (10) : 3739 - 3744
  • [2] A Fusion Intermediate gp41 Immunogen Elicits Neutralizing Antibodies to HIV-1
    Lai, Rachel P. J.
    Hock, Miriam
    Radzimanowski, Jens
    Tonks, Paul
    Hulsik, David Lutje
    Effantin, Gregory
    Seilly, David J.
    Dreja, Hanna
    Kliche, Alexander
    Wagner, Ralf
    Barnett, Susan W.
    Tumba, Nancy
    Morris, Lynn
    LaBranche, Celia C.
    Montefiori, David C.
    Seaman, Michael S.
    Heeney, Jonathan L.
    Weissenhorn, Winfried
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (43) : 29912 - 29926
  • [3] Identification of a novel HIV-1 neutralizing antibody using synthetic peptides that mimic a gp41 fusion intermediate
    Bianchi, E
    Geleziunas, R
    Barbato, G
    Ingallinella, P
    Finotto, M
    Hrin, R
    Lu, M
    Zhang, H
    Lennard, S
    Lowe, D
    Ciliberto, G
    Hazuda, D
    Cortese, R
    Miller, M
    Shiver, J
    Pessi, A
    BIOPOLYMERS, 2005, 80 (04) : 576 - 576
  • [4] Identification of a novel HIV-1 neutralizing antibody using synthetic peptides that mimic a GP41 fusion intermediate
    Bianchi, Elisabetta
    Miller, Michael D.
    Geleziunas, Romas
    Barbato, Gaetano
    Ingallinella, Paolo
    Finotto, Marco
    Hrin, Renee
    Lu, Meiqing
    Lennard, Simon
    Lowe, David
    Ciliberto, Gennaro
    Hazuda, Daria
    Cortese, Riccardo
    Shiver, John
    Pessi, Antonello
    UNDERSTANDING BIOLOGY USING PEPTIDES, 2006, : 569 - +
  • [5] Vaccination induces broadly neutralizing antibody precursors to HIV gp41
    Schiffner, Torben
    Phung, Ivy
    Ray, Rashmi
    Irimia, Adriana
    Tian, Ming
    Swanson, Olivia
    Lee, Jeong Hyun
    Lee, Chang-Chun D.
    Marina-Zarate, Ester
    Cho, So Yeon
    Huang, Jiachen
    Ozorowski, Gabriel
    Skog, Patrick D.
    Serra, Andreia M.
    Rantalainen, Kimmo
    Allen, Joel D.
    Baboo, Sabyasachi
    Rodriguez, Oscar L.
    Himansu, Sunny
    Zhou, Jianfu
    Hurtado, Jonathan
    Flynn, Claudia T.
    Mckenney, Katherine
    Havenar-Daughton, Colin
    Saha, Swati
    Shields, Kaitlyn
    Schulze, Steven
    Smith, Melissa L.
    Liang, Chi-Hui
    Toy, Laura
    Pecetta, Simone
    Lin, Ying-Cing
    Willis, Jordan R.
    Sesterhenn, Fabian
    Kulp, Daniel W.
    Hu, Xiaozhen
    Cottrell, Christopher A.
    Zhou, Xiaoya
    Ruiz, Jennifer
    Wang, Xuesong
    Nair, Usha
    Kirsch, Kathrin H.
    Cheng, Hwei-Ling
    Davis, Jillian
    Kalyuzhniy, Oleksandr
    Liguori, Alessia
    Diedrich, Jolene K.
    Ngo, Julia T.
    Lewis, Vanessa
    Phelps, Nicole
    NATURE IMMUNOLOGY, 2024, 25 (06) : 1073 - 1082
  • [6] HIV-1 gp41 Fusion Intermediate: A Target for HIV Therapeutics
    Pan, Chungen
    Liu, Shuwen
    Jiang, Shibo
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2010, 109 (02) : 94 - 105
  • [7] Structural basis for HIV-1 neutralization by a gp41 fusion intermediate–directed antibody
    Micah A Luftig
    Marco Mattu
    Paolo Di Giovine
    Romas Geleziunas
    Renee Hrin
    Gaetano Barbato
    Elisabetta Bianchi
    Michael D Miller
    Antonello Pessi
    Andrea Carfí
    Nature Structural & Molecular Biology, 2006, 13 : 740 - 747
  • [8] HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development
    Verkoczy, Laurent
    Kelsoe, Garnett
    Haynes, Barton F.
    PLOS PATHOGENS, 2014, 10 (05)
  • [9] Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody
    Luftig, Micah A.
    Mattu, Marco
    Di Giovine, Paolo
    Geleziunas, Romas
    Hrin, Renee
    Barbato, Gaetano
    Bianchi, Elisabetta
    Miller, Michael D.
    Pessi, Antonello
    Carfi, Andrea
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2006, 13 (08) : 740 - 747
  • [10] Neutralizing Antibodies Targeting HIV-1 gp41
    Caillat, Christophe
    Guilligay, Delphine
    Sulbaran, Guidenn
    Weissenhorn, Winfried
    VIRUSES-BASEL, 2020, 12 (11):